Results

Total Results: 91 records

Showing results for "treatment".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/476/CDS%20Pain%20Management%20Summary%20Quick%20Start%20Guide_final_1.pdf
    July 23, 2024 - Activity (PEG) Assessments – scores and dates  STarT Back Assessments – scores and dates Historical treatments … statements with dates  Non-Opioid Medications – orders and statements with dates  Non-Pharmacologic Treatments … dysfunction, Hepatic dysfunction, Pregnancy, 65 yrs or older) Pain Assessments  No flags Historical treatments …  Opioid Medications: Flag if present  Non-opioid Medications: Flag if NONE  Non-pharmacologic Treatments
  2. cds.ahrq.gov/sites/default/files/cds/artifact/1181/Logic_Flow_Brief_Intervention_and_Referral_CDS.pdf
    July 14, 2020 - Brief Behavioral Counseling Interventions for Excessive Alcohol Consumption with Optional Referral to Treatment … Brief Behavioral Counseling Interventions for Excessive Alcohol Consumption with Optional Referral to Treatment
  3. cds.ahrq.gov/sites/default/files/Overview%20Summary%20Sheet%20CDS%20Connect%20Patient%20Partnering%20Panel%202021.pdf
    July 18, 2023 - The literature on patient participation in treatment and care (patient engagement/patient activation … • Identify and describe factors that impact patient and care giving decision making (e.g., cost of treatment
  4. cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_5_Actions.html
    July 25, 2018 - on the Management of Community-Acquired Pneumonia in Adults Actions and Directives more-intensive treatment … such as the CURB-65 criteria to identify patients with CAP who may be candidates for out- patient treatment
  5. cds.ahrq.gov/sites/default/files/workgroups/27826/CDS_Connect_WG_Summary_July_2021.pdf
    January 01, 2021 - following a step-care framework for selecting medications for asthma diagnosis, management, and treatment … In addition to its recommendations about treatment and prescription updates for mild, moderate, and severe … take a “guardrail approach” to CDS alerting: The artifact would provide recommendations for preferred therapies … If a provider escalates a patient’s therapy to the next step of preferred therapy, then no notification … take a “living guideline” approach to the artifact by updating recommendations as new evidence and treatments
  6. cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_1_Recommendations.html
    January 01, 1970 - Severity Index (PSI), can be used to identify patients with CAP who may be candidates for outpatient treatment … {Rec_1:Imp_ 2} Conditional: For patients with CURB-65 scores ≥2, more-intensive treatment
  7. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - CDS Connect Implementation Guide Draft Implementation Guide Statin Therapy for the Prevention and Treatment … Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD) … Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality … Figure 1: Artifact Relationship Diagram Testing The Statin Therapy for the Prevention and Treatment … CQL Q&As on the eCQI Resource Center Statin Therapy for the Prevention and Treatment of Cardiovascular
  8. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
    June 07, 2019 - The artifact is a CDS rule representation of CDC clinical guidance for antimicrobial therapy and anthrax … This CDS uses the overarching ingredient code for the antimicrobial therapy [12]. 5. … Second, because PEP requires 60 days of antimicrobial therapy and three vaccines administered at least … and levels of physical and/or cognitive impairment; and issues related to the specific medication therapy … FHIR resources that contain ingredient/substance codes for any of the potentially recommended PEP treatments
  9. cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - · Discuss Remaining Repository Questions · Clarify 10-Year Risk Assessment Details · Discuss Statin Therapy … for the Prevention and Treatment of CVD eCQM/CDS Artifact · Discuss Next Artifacts for Development · … Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact Quality Insights of … They provided an overview of a statin therapy measure available as a registry measure under the Physician … Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact Not discussed.
  10. cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD) … the Prevention and Treatment of Cardiovascular Disease (CVD): An Electronic Clinical Quality Measure … Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality … for the Prevention and Treatment of Cardiovascular Disease”). … Treatments and counseling for active ASCVD are outside the of scope of this artifact.
  11. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
    October 17, 2018 - clinician under certain conditions (e.g., a documented patient allergy to one of the recommended treatments … It references the ActionList and the ContainedResourcesList, which contain the recommended treatments … If treatment is not recommended, then this resource will be empty. … ’s GMF allows detailed models to be built up that can describe the nature and timing of diseases, treatments … All other patients proceed to the antimicrobial treatment section.
  12. cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - considered as up to date based on the concept of screening, the numerator of this measure outlines treatments … rules to place patients in buckets based on the 4 risk groups that could benefit from lipid lowering therapy … This will ensure that the right person gets the right treatment. · Individuals with clinical ASCVD · … For this reason, CMS64 may be out of date since it prompts treatment against LDL goals instead of against … considered as up to date based on the concept of risk assessment, the numerator of this measure outlines treatments
  13. cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
    January 01, 2021 - The CDS artifact also targets the point when the clinician selects or signs for the treatment (known … the potential harm posed by select PDDIs; it also facilitates conversations about preferences and treatment … Using another example (treatment of pain), Dr.
  14. cds.ahrq.gov/taxonomy/term/2001
    August 23, 2024 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  15. cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - Use only if benefit outweighs risk · Rationale: Increased bleeding risk likely Name of PDDIStatin Therapy … for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure 6 Version … for the Prevention and Treatment of Cardiovascular Disease (CVD) Electronic Clinical Quality Measure … How Artifact Operates Within CQL The Statin Therapy for the Prevention and Treatment of Cardiovascular … for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure 12 Version
  16. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-09/Wells%20Criteria.txt
    January 01, 2023 - previous 4 weeks (1.5 points) - Previous DVT/PE (1.5 points) - Hemoptysis (1 point) - Malignancy (on treatment
  17. cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
    January 01, 2017 - newest artifacts under development: Statin Use for the Primary Prevention of CVD in Adults and Aspirin Therapy … 190 in the exclusion criteria with familial hypercholesterolemia makes sense because it may warrant treatment … You might not want to trigger a recommendation to lower statin therapy if a patient was started on a … If the LDL lowers on treatment, a lower intensity may not be indicated. … addressing the moving target of risk given the new Million Heart model and its ability to lower risk after treatment
  18. cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
    September 01, 2018 - to support shared decision making on treatment moving forward. … Did the CDS improve the quality of patient care in the pilot facility (e.g., identify risk, inform treatment … plan or prescribing practices, improve followup treatment)? … • Non-phamiacologic Treatments: Flag if NONE. … clinical concepts: • Observations are filtered to only those with category: laboratory, survey, or therapy
  19. cds.ahrq.gov/sites/default/files/cds/artifact/66551/GuidanceForOsteoporosis_Integration_FlowChart.pdf
    July 18, 2023 - Recommendations, label, talking point and button associated with the active fall risk conditions and treatments
  20. cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
    January 01, 2015 - ; the person’s compliance with and response to treatment; and the person’s ability to recognize symptoms … Does treatment of his diabetes change because he is in a job with risk for serious falls? … May an employer ask a job applicant whether she has or had diabetes or about her treatment related …  leave for treatment, recuperation, or training on managing diabetes18  modified work schedule … Standard treatment for new onset type 2 Page 26 of 30 diabetes includes metformin, ACE inhibitor

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: